StockData
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31

ANGIODYNAMICS INC

Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$11.39+0.15 (+1.33%)

Close on Oct 19, 2026

Market cap
$478.63M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Jan 5, 2027, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2027
Ended Aug 31, 2026
Oct 8, 2026Before market open$80.90M$-0.17$-0.04
Q4 FY2026
Ended May 31, 2026
Jul 14, 2026Before market open$86.60M$-0.27$-0.07
Q3 FY2026
Ended Feb 28, 2026
Apr 2, 2026Before market open$78.40M$-0.19$-0.07
Q2 FY2026
Ended Nov 30, 2025
Jan 6, 2026Before market open$79.40M$-0.15$0.00
Q1 FY2026
Ended Aug 31, 2025
Oct 2, 2025Before market open$75.70M$-0.26$-0.10
Q4 FY2025
Ended May 31, 2025
Jul 15, 2025Before market open$80.20M$-0.15$-0.03
Q3 FY2025
Ended Feb 28, 2025
Apr 2, 2025Before market open$72.00M$-0.11$-0.08
Q2 FY2025
Ended Nov 30, 2024
Jan 8, 2025Before market open$73.00M$-0.26$-0.04
Q1 FY2025
Ended Aug 31, 2024
Oct 3, 2024Before market open$67.50M$0.31$0.11
Q4 FY2024
Ended May 31, 2024
Jul 16, 2024Before market open$75.18M$-4.67$-0.16
Q3 FY2024
Ended Feb 29, 2024
Apr 4, 2024Before market open–––

Company guidance

Outlook given with results on Oct 8, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Adjusted EBITDAnon-GAAPfiscal year 2027$13.00M to $16.00MMaintained
Adjusted EPSnon-GAAPfiscal year 2027$-0.29 to $-0.24Maintained
Gross Marginfiscal year 202754% to 55%Maintained
Med Tech Net Sales Growthfiscal year 202712% to 15% growthMaintained
Net Salesfiscal year 2027$336.00M to $341.00MMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Angiodynamics filed with the SEC